Medicare Advantage
The AHA urged the Centers for Medicare & Medicaid Services to revise and reissue recent proposed regulations streamlining prior authorization requirements within certain coverage programs; consider additional regulations to limit care delays; and conduct oversight and enforcement for plans who…
The Centers for Medicare & Medicaid Services released its star ratings for 2022 Medicare Advantage and prescription drug plans, which are available through the Medicare plan finder tool and CMS website.
The Centers for Medicare & Medicaid Services released premium and cost-sharing information for Medicare Advantage and Part D prescription drug plans for the 2022 calendar year.
The Centers for Medicare & Medicaid Services (CMS) today issued a Health Plan Management System memo to all Medicare Advantage Organizations (MAO) and Medicare-Medicaid Plans to strongly encourage them to waive or relax plan prior authorization requirements and utilization management processes…
The Centers for Medicare & Medicaid Services issued a Health Plan Management System memo to all Medicare Advantage Organizations and Medicare-Medicaid Plans to strongly encourage them to waive or relax plan prior authorization requirements and utilization management processes to facilitate the…
The AHA today expressed support for the Improving Seniors’ Timely Access to Care Act of 2021 (H.R. 3173), bipartisan legislation that would establish requirements for the use of prior authorization under Medicare Advantage plans.
The American Hospital Association voices support of the Improving Seniors’ Timely Access to Care Act of 2021 (H.R. 3173).
Resources from the Hospice and Home Health Challenges with Medicare Advantage member call, March 30, 2021.
The AHA urged the Centers for Medicare & Medicaid Services to use its oversight authority for Medicare Advantage, Medicaid managed care, Children’s Health Insurance Program and Health Insurance Marketplace health plans to prevent UnitedHealthcare from implementing certain diagnostic and…
The Centers for Medicare & Medicaid Services finalized additional provisions for the Medicare Advantage and Part D prescription drug programs beginning in 2022.